Litigation Details for MEDA PHARMACEUTICALS INC. v. AUROBINDO PHARMA LIMITED (D.N.J. 2019)
✉ Email this page to a colleague
MEDA PHARMACEUTICALS INC. v. AUROBINDO PHARMA LIMITED (D.N.J. 2019)
| Docket | ⤷ Subscribe | Date Filed | 2019-02-12 |
| Court | District Court, D. New Jersey | Date Terminated | 2019-08-02 |
| Cause | 28:1338 Patent Infringement | Assigned To | Brian R. Martinotti |
| Jury Demand | None | Referred To | Tonianne J. Bongiovanni |
| Patents | 8,071,073; 8,518,919; 9,919,050 | ||
| Link to Docket | External link to docket | ||
Small Molecule Drugs cited in MEDA PHARMACEUTICALS INC. v. AUROBINDO PHARMA LIMITED
The small molecule drugs covered by the patents cited in this case are ⤷ Subscribe and ⤷ Subscribe .
Details for MEDA PHARMACEUTICALS INC. v. AUROBINDO PHARMA LIMITED (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 0000-00-00 | External link to document | |||
| 2019-02-11 | 1 | United States Patent Nos. 8,071,073 (“the ’073 patent”), 8,518,919 (“the ’919 patent”), and 9,919,050… INFRINGEMENT OF U.S. PATENT NO. 8,071,073 29. Plaintiff repeats and realleges…9,919,050 (“the ’050 patent”) arising under the Patent Laws of the United States, Title 35, United States Code… THE PATENTS-IN-SUIT 12. The ’073 patent, titled “Compositions comprising…forth in greater detail in the ’073 patent, the claims of the ’073 patent are directed to, inter alia, methods | External link to document | |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
